- Home
- DERM vs REFI Comparison
DERM vs REFI Comparison
Compare DERM & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DERM | REFI |
|---|---|---|
| Founded | 2014 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.4M | 255.6M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DERM | REFI |
|---|---|---|
| Price | $8.19 | $12.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $12.67 | ★ $20.00 |
| AVG Volume (30 Days) | 98.1K | ★ 121.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 16.79% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.30 |
| Revenue | ★ $56,134,000.00 | $48,857,628.00 |
| Revenue This Year | $17.48 | $13.69 |
| Revenue Next Year | $55.83 | $3.55 |
| P/E Ratio | ★ N/A | $9.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.99 | $11.62 |
| 52 Week High | $9.56 | $16.15 |
Technical Indicators
Market Signals| Indicator | DERM | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 51.40 |
| Support Level | $6.92 | $12.23 |
| Resistance Level | $8.71 | $12.49 |
| Average True Range (ATR) | 0.43 | 0.24 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 36.20 | 74.21 |
Price Performance
Historical ComparisonAbout DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.